polio vaccines vaccines used prevent poliomyelitis two types used inactivated poliovirus given injection ipv weakened poliovirus given mouth world health organization recommends children fully vaccinated two vaccines eliminated polio reduced number cases reported year estimated inactivated polio vaccines mild redness pain may occur site oral polio vaccines cause three cases vaccineassociated paralytic poliomyelitis per million doses compares cases per million paralysed following polio types vaccine generally safe give pregnancy hivaids otherwise however emergence circulating vaccinederived poliovirus cvdpv form vaccine virus reverted causing poliomyelitis led development novel oral polio vaccine type aims make vaccine safer thus stop outbreaks first successful demonstration polio vaccine hilary koprowski live attenuated virus people vaccine approved use united states used successfully success inactivated killed polio vaccine developed jonas salk announced another attenuated live oral polio vaccine developed albert sabin came commercial use polio vaccine world health organizations list essential interruption persontoperson transmission virus vaccination important global polio since longterm carrier state exists poliovirus individuals normal immune function polio viruses nonprimate reservoir survival virus environment extended period time appears remote two types vaccine inactivated polio vaccine ipv oral polio vaccine opv ipv injection used individuals develop protective antibodies three serotypes polio virus two doses inactivated polio vaccine ipv least immune polio virus following three doses duration immunity induced ipv known certainty although complete series thought provide protection many ipv replaced oral vaccine many developed countries mainly due small risk vaccinederived polio oral oral polio vaccines easier administer ipv eliminated need sterile syringes therefore suitable mass vaccination campaigns opv also provided longerlasting immunity salk vaccine provides humoral immunity cellmediated one dose opv produces immunity three poliovirus serotypes roughly three doses liveattenuated opv produce protective antibodies three poliovirus types recipients opv produces excellent immunity intestine primary site wild poliovirus entry helps prevent infection wild virus areas virus live virus used vaccine rarely shed stool rarely spread others within community live virus also stringent requirements transport storage problem hot remote areas livevirus vaccines immunity initiated opv probably trivalent wild types opv used nearly eradicate polio infection led global polio eradication initiative countries switched use bivalent wild types april may bivalent opv effective types cover type united states continues recommend use trivalent version fully inactivated switch bivalent vaccine associated missing immunity type strains among factors led outbreaks circulating vaccinederived poliovirus type increased cases cases response novel oral polio vaccine type developed aim provide safer form vaccination type strains less risk reverting infectious countries endemic polio risk imported cases high recommends opv vaccine birth followed primary series three opv doses least one ipv dose starting weeks age minimum weeks opv doses countries immunization coverage low risk importation recommends one two ipv doses starting months age followed least two opv doses doses separated weeks depending risk exposure countries highest levels coverage lowest risks importation transmission recommends primary series three ipv injections booster dose interval six months first dose administered months inactivated polio vaccines safe mild redness pain may occur site injection oral polio vaccine results vaccineassociated paralytic poliomyelitis three per million doses generally safe give pregnant hivaids otherwise inactivated polio vaccine cause allergic reaction people since vaccine contains trace amounts antibiotics streptomycin polymyxin b neomycin given anyone allergic reaction medicines signs symptoms allergic reaction usually appear within minutes hours receiving injected vaccine include breathing difficulties weakness hoarseness wheezing heart rate fluctuations skin rash potential adverse effect opv known ability recombine form causes neurological infection genetic reversal pathogen virulent form takes considerable time least months affect person originally vaccinated vaccinederived attenuated virus normally excreted vaccinated people limited period thus areas poor sanitation low vaccination coverage spontaneous reversal vaccinederived virus virulent form spreading environment lead unvaccinated people becoming clinical disease including paralysis caused vaccinederived poliovirus vdpv indistinguishable caused wild outbreaks vaccineassociated paralytic poliomyelitis vapp caused circulating vaccinederived poliovirus reported tend occur areas low coverage opv presumably opv protective related outbreak wild polio cases record lows first year cases cvdpv recorded wild poliovirus trend expected combat decided switch trivalent polio vaccine bivalent polio vaccine longer contains type polio virus eradicated rhesus monkey kidney cells used prepare poliovirus vaccines determined infected simian also discovered naturally occurring virus infects monkeys found cause tumors recently virus found certain forms cancer humans instance brain bone tumors pleural peritoneal mesothelioma types nonhodgkin however determined cause found present stocks injected form ipv use found opv million americans received one doses polio vaccine proportion vaccine contaminated estimated million americans may received dose vaccine contaminated later analysis suggested vaccines produced former soviet bloc countries used ussr china japan several african countries may contaminated meaning hundreds millions may exposed national cancer institute undertook large study using cancer case information institutes seer database published findings study revealed increased incidence cancer persons may received vaccine containing another large study sweden examined cancer rates individuals received potentially contaminated polio vaccine late study revealed increased cancer incidence persons received polio vaccines containing question whether causes cancer humans remains controversial however development improved assays detection human tissues needed resolve race develop oral polio vaccine several largescale human trials undertaken national institutes health determined opv produced using sabin strains however hilary koprowski continued administer vaccine around world africa vaccines administered roughly one million people belgian territories democratic republic congo rwanda results human trials unfounded accusations arose vaccine created conditions necessary transmission simian immunodeficiency virus chimpanzees humans causing hivaids hypotheses however conclusively cases poliomyelitis africa reduced small number isolated regions western portion continent sporadic cases elsewhere recent local opposition vaccination campaigns evolved due lack adequate often relating fears vaccine might induce disease since resurged nigeria several african nations without necessary information epidemiologists believe due refusals certain local populations allow children receive polio salk vaccine ipv based three wild virulent reference strains mahoney type poliovirus type poliovirus saukett type poliovirus grown type monkey kidney tissue culture vero cell line inactivated injected salk vaccine confers iggmediated immunity bloodstream prevents polio infection progressing viremia protects motor neurons thus eliminating risk bulbar polio postpolio syndrome united states vaccine administered along tetanus diphtheria acellular pertussis vaccines dtap pediatric dose hepatitis b uk ipv combined tetanus diphtheria pertussis haemophilus influenzae type b opv attenuated vaccine produced passage virus nonhuman cells subphysiological temperature produces spontaneous mutations viral oral polio vaccines developed several groups one led albert sabin groups led hilary koprowski hr cox developed attenuated vaccine strains national institutes health created special committee live polio vaccines various vaccines carefully evaluated ability induce immunity polio retaining low incidence neuropathogenicity monkeys largescale clinical trials performed soviet union late early mikhail chumakov colleagues demonstrated safety high efficacy based results sabin strains chosen worldwide fiftyseven nucleotide substitutions distinguish attenuated sabin strain virulent parent mahoney serotype two nucleotide substitutions attenuate sabin strain substitutions involved attenuating sabin primary attenuating factor common three sabin vaccines mutation located viruss internal ribosome entry alters stemloop structures reduces ability poliovirus translate rna template within host attenuated poliovirus sabin vaccine replicates efficiently gut primary site infection replication unable replicate efficiently within nervous system tissue type monovalent oral poliovirus vaccine mopv licensed type mopv licensed trivalent opv topv licensed became vaccine choice united states countries world largely replacing inactivated polio second wave mass immunizations led dramatic decline number polio cases million americans roughly population time received sabin vaccine result substantial reduction number poliomyelitis cases even muchreduced levels following introduction salk opv usually provided vials containing doses vaccine single dose oral polio vaccine usually two drops contains infectious units sabin effective infectious units sabin strain infectious units sabin vaccine contains small traces contain generic sense vaccination works priming immune system immunogen stimulating immune response use infectious agent known immunization development immunity polio efficiently blocks persontoperson transmission wild poliovirus thereby protecting individual vaccine recipients wider development two polio vaccines led first modern mass inoculations last cases paralytic poliomyelitis caused endemic transmission wild virus united states occurred outbreak among amish several midwest poliovirus perceived especially terrifying little known disease transmitted could prevented virus also notable primarily impacting affluent children making prime target vaccine development despite relatively low mortality despite community researchers field thus far largely observed informal moratorium vaccine development perceived present high risk little likelihood shifted early american groups took challenge maurice brodie led team public health laboratory city new york john kolmer collaborated research institute cutaneous medicine philadelphia rivalry two researchers lent racelike mentality combined lack oversight medical studies reflected methodology outcomes early vaccine development kolmer began vaccine development project ultimately focused producing attenuated live virus vaccine inspired success vaccines rabies yellow fever hoped use similar process denature polio order go attenuating polio vaccine repeatedly passed virus using methods production later described hairraisingly amateurish therapeutic equivalent bathtub kolmer ground spinal cords infected monkeys soaked salt solution filtered solution mesh treated ricinolate refrigerated product ultimately create would later prominently critiqued veritable witches keeping norms time kolmer completed relatively small animal trial monkeys proceeding self experimentation tested vaccine upon two children gave vaccine children declaring safe sending doctors health departments larger test april able report tested vaccine children without ill kolmers first formal presentation results would come november presented results children adults vaccinated attenuated also reported together research institute cutaneous medicine merrell company cincinnati manufacturer held patent ricinoleating process distributed doses vaccine physicians across united states kolmer describe monitoring experimental vaccination program provide physicians instructions administer vaccine report side kolmer dedicated bulk publications thereafter explaining believed cause reported cases paralytic polio following vaccination many cases towns polio outbreak six cases kolmer control group asserted many children would gotten nearly time kolmers project maurice brodie joined immunologist william h park new york city health department worked together poliovirus aid grant funding presidents birthday ball commission predecessor would become march dimes brodie able pursue development inactivated killed virus vaccine brodies process also began grinding spinal cords infectious monkeys treating cords various ultimately finding solution formaldehyde effective june brodie able publish first scholarly article describing successful induction immunity three monkeys inactivated polio continued study additional monkeys brodie ultimately concluded administration live virus vaccine tended result humoral immunity administration killed virus vaccine tended result tissue soon following similar protocol kolmer brodie proceeded self experimentation upon coworkers nyc health department brodies progress eagerly covered popular press public hoped successful vaccine become reporting make mention children new york city asylum subjected early safety none subjects experienced ill effects park described contemporaries never one let grass grow declared vaccine severe polio outbreak overwhelmed kern county california became first trial site new vaccine short notice november may doses vaccine administered kern county initial results promising insufficient staffing poor protocol design left brodie open criticism published california results august private physicians brodie also conducted broader field study including children received vaccine age locationmatched controls receive vaccine results promising received vaccine went develop polio exposed prior vaccination none received full series vaccine doses additionally polio epidemic raleigh north carolina provided opportunity us public health service conduct highly structured trial brodie vaccine using funding birthday ball work ongoing larger community bacteriologists began raise concerns regarding safety efficacy new poliovirus time little oversight medical studies ethical treatment study participants largely relied upon moral pressure peer academic brodies inactivated vaccines faced scrutiny many felt killed virus vaccines could efficacious researchers able replicate tissue immunity produced animal trials prevailing wisdom humoral immunity essential efficacious kolmer directly questioned killed virus approach scholarly kolmers studies however raised even concern increasing reports children becoming paralysed following vaccination live virus vaccine notably paralysis beginning arm rather foot many kolmer brodie called present research annual meeting american public health association milwaukee wi october additionally thomas rivers asked discuss presented papers prominent critic vaccine development resulted apha arranging symposium poliomyelitis delivered annual meeting southern branch following discussion meeting james leake us public health service stood immediately present clinical evidence kolmer vaccine caused several deaths allegedly accused kolmer rivers recalled oral history hell broke loose seemed everybody trying talk timejimmy leake used strongest language ever heard used scientific response attacks sides brodie reported stood stated looks though according dr rivers vaccine good according dr leake dr kolmers kolmer simply responded stating gentlemen one time wish floor would open swallow ultimately kolmers live vaccine undoubtedly shown dangerous already withdrawn september prior milwaukee consensus symposium largely skeptical efficacy brodies vaccine safety question recommendation much larger wellcontrolled however three children became ill paralytic polio following dose vaccine directors warm springs foundation georgia acting primary funders project requested withdrawn december following withdrawal previously observed moratorium human poliomyelitis vaccine development resumed would another attempt nearly brodie arguably made progress pursuit poliovirus vaccine suffered significant career repercussions due status less widely known modern researchers recognize brodie may well developed effective polio vaccine however basic science technology time insufficient understand utilize brodies work using formalininactivated virus would later become basis salk vaccine would live see brodie fired position within three months symposiums able find another laboratory position died heart attack three years later age contrast park believed community reaching senility point older age able retire position prior death kolmer already established well respected researcher returned temple university professor kolmer productive career receiving multiple awards publishing countless papers articles textbooks retirement breakthrough came research group headed john enders childrens hospital boston successfully cultivated poliovirus human tissue group recently successfully grown mumps cell culture march thomas h weller attempting grow varicella virus embryonic lung tissue inoculated planned number tubes noticed unused tubes retrieved sample mouse brain infected poliovirus added remaining test tubes chance virus might grow varicella cultures failed grow polio cultures successful development greatly facilitated vaccine research ultimately allowed development vaccines polio enders colleagues thomas h weller frederick c robbins recognized efforts nobel prize physiology important advances led development polio vaccines identification three poliovirus serotypes poliovirus type mahoney lansing leon finding prior paralysis virus must present blood demonstration administration antibodies form gamma globulin protects paralytic early polio rates us annually us experienced outbreak polio cases respectively typical number year deaths years numbering amid us polio epidemic millions dollars invested finding marketing polio vaccine commercial interests including lederle laboratories new york direction h r cox also working lederle polishborn virologist immunologist hilary koprowski wistar institute philadelphia tested first successful polio vaccine vaccine however live attenuated virus taken orally still research stage would ready use five years jonas salks polio vaccine deadvirus injectable vaccine reached market koprowskis attenuated vaccine prepared successive passages brains swiss albino mice seventh passage vaccine strains could longer infect nervous tissue cause paralysis one three passages rats vaccine deemed safe human february koprowskis live attenuated vaccine tested first time boy living letchworth village institution physically mentally disabled people located new york child side effects koprowski enlarged experiment include first effective polio vaccine developed jonas salk team university pittsburgh included julius youngner byron bennett l james lewis lorraine friedman required years subsequent testing salk went cbs radio report successful test small group adults children march two days later results published leone n farrell invented key laboratory technique enabled mass production vaccine team led beginning february vaccine tested arsenal elementary school watson home children pittsburgh salks vaccine used test called francis field trial led thomas francis largest medical experiment history time test began children franklin sherman elementary school mclean eventually involved million children states maine conclusion study roughly received one injections vaccine children received placebo consisting harmless culture media million children received vaccination served control group would observed see contracted results field trial announced april tenth anniversary death president franklin roosevelt whose paralytic illness generally believed caused polio salk vaccine effective poliovirus type effective effective development bulbar soon salks vaccine licensed childrens vaccination campaigns launched us following mass immunization campaign promoted march dimes annual number polio cases fell cases recorded united week announcement francis field trial results april pierre l√©pine pasteur institute paris also announced effective polio april soon mass polio vaccination began us surgeon general began receive reports patients contracted paralytic polio week vaccinated salk polio vaccine cutter pharmaceutical company paralysis starting limb vaccine injected cutter vaccine used vaccinating children western midwestern united later investigations showed cutter vaccine caused cases polio killing response surgeon general pulled polio vaccines made cutter laboratories market cases paralytic illness occurred eli lilly parkedavis pitmanmoore wyeth polio vaccines also reported paralyzed numerous children soon discovered lots salk polio vaccine made cutter wyeth labs properly inactivated allowing live poliovirus doses vaccine may national institutes health public health services established technical committee poliomyelitis vaccine test review polio vaccine lots advise public health service lots released public use incidents reduced public confidence polio vaccine leading drop vaccination time salk testing vaccine albert sabin hilary koprowski continued working developing vaccine using live virus meeting stockholm discuss polio vaccines november sabin presented results obtained group volunteers koprowski read paper detailing findings trial enrolling sabin koprowski eventually succeeded developing vaccines commitment salk vaccine america sabin koprowski testing outside united states sabin soviet koprowski congo sabin developed trivalent vaccine containing attenuated strains three types ten million children soviet union received sabin oral vaccine work sabin given medal order friendship peoples described soviet unions highest civilian sabins oral vaccine using live virus came commercial use sabins oral vaccine became widely available supplanted salks injected vaccine tarnished publics opinion cutter incident salk vaccines improperly prepared one company resulted several children dying becoming enhancedpotency ipv licensed united states november currently vaccine choice first dose polio vaccine given shortly birth usually months age second dose given months timing third dose depends vaccine formulation given months booster vaccination given years age total four doses school countries fifth vaccination given routine vaccination adults years age older developed countries neither necessary recommended adults already immune small risk exposure wild poliovirus home pentavalent fivecomponent combination vaccine called containing ipv approved use united global effort eradicate polio led world health organization rotary foundation began relied largely oral polio vaccine developed albert sabin mikhail chumakov sabinchumakov polio eliminated americas disease officially eliminated western pacific countries including china australia europe declared poliofree since january cases disease reported india hence february country taken list polioendemic countries march india declared poliofree although poliovirus transmission interrupted much world transmission wild poliovirus continue creates ongoing risk importation wild poliovirus previously poliofree regions importations poliovirus occur outbreaks poliomyelitis may develop especially areas low vaccination coverage poor sanitation result high levels vaccination coverage must november announced polio outbreak syria response armenian government put notice asking syrian armenians age get polio polio virus spread countries mainly africa asia middle east pakistan syria cameroon advising vaccinations outbound polio vaccination programs resisted people pakistan afghanistan nigeria three countries remaining polio cases almost muslim religious political leaders endorsed fringe minority believes vaccines secretly used sterilization fact cia organized fake vaccination program help find osama bin laden additional cause announced deal taliban encourage distribute vaccine areas however pakistani taliban supportive september two unidentified gunmen associated pakistani taliban jamaatulahrar shot zakaullah khan doctor administering polio vaccines pakistan leader jamaatulahrar claimed responsibility shooting stated group would continue type attack resistance skepticism vaccinations consequently slowed polio eradication process within two remaining endemic travellers wish enter leave certain countries must vaccinated polio usually months least weeks crossing border able present vaccination recordcertificate border requirements apply travel socalled polioendemic polioaffected polioexporting poliotransmission highrisk august afghanistan pakistan polioendemic countries world wild polio yet several countries additional precautionary polio vaccination travel requirements example key atrisk countries december include china indonesia mozambique myanmar papua new global alliance vaccines immunization supplies inactivated vaccine developing countries little per dose misconception present pakistan polio vaccine contained haram ingredients could cause impotence infertility male children leading parents children vaccinated belief common khyber pakhtunkhwa province fata region attacks polio vaccination teams also occurred thereby hampering international efforts eradicate polio pakistan httpsenwikipediaorgwikipoliovaccine